Reminders

Changing Life Sciences Value Chain

Archives for June 2010 « Recent Articles

OfflinePhoto of Dr. Alan S. Louie

One should expect that any quote from a politician that is included in a discussion on the globalization of clinical trials is going to bring an agenda … and present a heavily one sided slant on the issue.  In this case it was a democrat in a New York Times article, positing that the growth in the contribution of foreign clinical trial sites and patients to U.S. drug applications is a clear sign of exploitation of lower standards and limited FDA oversight in pursuit of lower costs and higher pro


OfflinePhoto of Eric Newmark

Most pharmaceutical companies today embrace outsourcing as a key piece of their core IT strategy. Given that success begins with selecting the right partner, we receive a significant amount of inquiries from our customers looking for information and guidance during their vendor evaluation process, to ensure a fully informed decision is made. To best support this,  every two years we publish a dual-series of buyers guides covering outsourcing firms servicing the manufacturing & supply chain space, a


OfflinePhoto of Dr. Alan S. Louie

No, I'm not talking about the second coming of the Terminator as the next blockbuster movie. And machine may be a bit of a stretch, although computers, servers, and even in vitro medical devices are all machines. What is becoming apparent, however, is that software applications and the devices that they are associated with or power are becoming increasingly intelligent and able to provide much more than a simple regurgitation of data on demand. Advances in technology and the decreasing cost of IT are drivin


OfflinePhoto of Eric Newmark

While the impact of healthcare reform (HCR) on the pharmaceutical industry turned out to be significantly less than many in the industry had feared, employees on different sides of pharmaceutical companies certainly have varying opinions on the significance of its "impact".



Viewed 703,317 times